pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,539 catalysts · 4,728 grant · 3,404 8k filing · 2,639 approval · 2,188 device 510k · 1,786 device recall · 1,536 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 24 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-08-04×clear all
type
  • grant4,728
  • 8k filing3,404
  • approval2,639
  • device 510k2,188
  • device recall1,786
  • device pma1,536
device adverse event
1,000
  • recall593
  • earnings584
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 15, 2025

    50
    ›Sep 18, 2025grant335d agoWASHINGTON UNIVERSITY — Curation of Muscular Dystrophy Genes

    AR grant. $290,137. PI: CONRAD C WEIHL

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoUNIVERSITY OF MONTANA — Mechanisms of Change in Behavioral Cough Suppression Treatment for Refractory...

    HL grant. $723,438. PI: Marie Elisabeth Jette

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoEMORY UNIVERSITY — From Evidence to Policy: Tailoring GLP-1RA Coverage for Optimal Health OutcomesEmory University

    DK grant. $802,363. PI: Mohammed Kumail Ali

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoOHIO STATE UNIVERSITY — Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stre...

    AA grant. $692,723. PI: Stephanie Gorka

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

    MH grant. $790,198. PI: LARRY ROBERT HEARLD

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoDUKE UNIVERSITY — Advancing a Holistic Understanding of Variability in Lived Experience with Si...Duke University

    HL grant. $1,049,682. PI: ALLISON E ASHLEY-KOCH

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoUNIVERSITY OF WASHINGTON — Researching Interventions and Implementation Strategies to Evaluate the Healt...University of Washington

    HD grant. $812,717. PI: Mary-Ann Davies

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoUNIVERSITY OF MARYLAND BALTIMORE — Investigation of neuraminidase as a target antigen for a universal influenza ...

    AI grant. $42,452. PI: Cosette Schneider

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoUnknown institution — SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].

    DA grant. $9,000

    full page →nih reporter ↗
    ›Sep 18, 2025grant335d agoUnknown institution — SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]....

    DA grant. $2,500

    full page →nih reporter ↗
    ›Sep 19, 2025approval334d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Sep 19, 2025approval334d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Sep 19, 2025approval334d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Sep 19, 2025approval334d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Sep 19, 2025approval334d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Sep 19, 2025approval334d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›Sep 19, 2025approval334d agoTREMFYA (GUSELKUMAB) — FDA approvalguselkumab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →guselkumab →fda approvals ↗
    ›Sep 19, 2025approval334d agoLEUPROLIDE ACETATE — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: SUN PHARM. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Sep 19, 2025approval334d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

    Sponsor: MEITHEAL. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →LEUPROLIDE ACETATE →fda approvals ↗
    ›Sep 19, 2025approval334d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

    Sponsor: MEITHEAL. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →LEUPROLIDE ACETATE →fda approvals ↗
    ›Sep 19, 2025approval334d agoLOPERAMIDE HYDROCHLORIDE — FDA approvalLOPERAMIDE HYDROCHLORIDE

    Sponsor: BIONPHARMA. Form: SOLUTION. Route: ORAL

    full page →LOPERAMIDE HYDROCHLORIDE →fda approvals ↗
    ›Sep 19, 2025approval334d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Sep 19, 2025approval334d agoFORZINITY (ELAMIPRETIDE HYDROCHLORIDE) — FDA approvalelamipretide hydrochloride

    Sponsor: STEALTH BIOTHERAPS. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →elamipretide hydrochloride →fda approvals ↗
    ›Sep 19, 2025approval334d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

    Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 19, 2025approval334d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

    Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 19, 2025approval334d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Sep 19, 2025approval334d agoPROGESTERONE — FDA approvalPROGESTERONE

    Sponsor: XIROMED. Form: INSERT. Route: VAGINAL

    full page →PROGESTERONE →fda approvals ↗
    ›Sep 19, 2025approval334d agoDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 19, 2025approval334d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 19, 2025approval334d agoLOSARTAN POTASSIUM — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 19, 2025approval334d agoPROPOFOL — FDA approvalPROPOFOL

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →PROPOFOL →fda approvals ↗
    ›Sep 19, 2025device 510k334d agoIbramed Equipamentos Médicos — VEGA (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoMedacta International S.A. — Coated hip implants (510k cleared)Stemedica International S.A.

    Product code: LZO. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoBunkerHill Health — Bunkerhill ECG-EF (510k cleared)

    Product code: QYE. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoMedica USA, Inc. — Purema H Hemoconcentrator - Pediatric (510k cleared)Medunik USA Inc

    Product code: KDI. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoShanghai United Imaging Healthcare Co., Ltd. — uDR Aurora CX (510k cleared)

    Product code: KPR. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoTempus AI, Inc. — xR IVD (510k cleared)Tempus AI, Inc.

    Product code: PZM. Advisory committee: Pathology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoOptmed, Inc. — BondEase 2 Topical Skin Adhesive (510k cleared)

    Product code: MPN. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoOlympus Medical Systems Corp. — EVIS EXERA III DUODENOVIDEOSCOPE OLYMPUS TJF-Q190V (TJF-Q190V) (510k cleared)

    Product code: FDT. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoIpg Medical Corporation — IPGTFL-02 (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoHuntleigh Healthcare , Ltd. — Sonicaid Team3 (510k cleared)

    Product code: HGM. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoNakanishi, Inc. — UniBur (510k cleared)

    Product code: HBE. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoAnhui Happiness Workshop Medical Instruments Co., Ltd. — Single Use Suction-Evacuation Ureteral Access Sheath (510k cleared)

    Product code: FED. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoVideahealth, Inc. — Videa Dental AI (510k cleared)

    Product code: MYN. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoShenzhen Jermei Medical Device Technology Co., Ltd. — Portable mesh nebulizer (JM821) (510k cleared)

    Product code: CAF. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoEmbody, Inc. — Tapestry Biointegrative Implant (510k cleared)

    Product code: OWY. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoGC America, Inc. — EQUIA LC ONE (510k cleared)PARKS AMERICA, INC

    Product code: EMA. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoVericom Co., Ltd. — Well-Root PT (510k cleared)

    Product code: KIF. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoNvision Biomedical Technologies, Inc. — Impact PEEK Union Nail System (510k cleared)

    Product code: HTY. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Sep 19, 2025device 510k334d agoUnibeauty (Hubei) Technology Co., Ltd. — Unscented menstrual three-piece applicator tampon (510k cleared)

    Product code: HEB. Advisory committee: Obstetrics/Gynecology. Type: Special

    full page →fda device 510k ↗
    ← prev
    page 54 of 371
    next →
    $PRKA
    $TEM
    $ANIP76.86+1.13%